Evidence map›Paper›PMID 41891920›Full record

ArticleACS chemical biology2026

Structural Studies of βTrCP Reveal Plasticity in Binding Modes of Consensus and Nonconsensus Degrons.

Gavin W Collie, Hazel Mak, Marta Acebrón-García-de-Eulate, Argyrides Argyrou, Maxime Couturier, Maria Emanuela Cuomo, Daniel H O Donovan, Isabella C Russell, Geoffrey Wells, Jon Winter-Holt

Abstract read
In one paragraph

Article in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gavin W CollieDiscovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.ORCID 0000-0002-0406-922X
Hazel MakDiscovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Marta Acebrón-García-de-EulateDiscovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.ORCID 0000-0002-6035-7525
Argyrides ArgyrouDiscovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.ORCID 0000-0003-3141-9122
Maxime CouturierDiscovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.ORCID 0009-0008-3031-3178
Maria Emanuela CuomoOncology R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Daniel H O DonovanOncology R&D, AstraZeneca, Cambridge CB2 0AA, U.K.ORCID 0000-0002-8400-2198
Isabella C RussellDiscovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Geoffrey WellsUCL School of Pharmacy, University College London, London WC1N 1AX, U.K.ORCID 0000-0002-0253-911X
Jon Winter-HoltOncology R&D, AstraZeneca, Cambridge CB2 0AA, U.K.ORCID 0000-0002-7776-5963

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The E3 ligase βTrCP regulates a significant number of important cytosolic proteins by recognizing and binding to a "DSGXXS" consensus phosphodegron sequence, resulting in the ubiquitination and degradation of target proteins. While many of the substrates of βTrCP have strong disease links, there is high-resolution structural data available for just one of these proteins in complex with βTrCP. Here, we describe the development of a robust crystallographic system for βTrCP and report high-resolution crystal structures for βTrCP in complex with degrons from five new targets, encompassing the important cancer proteins, WEE1, claspin, ATF4, PDCD4, and IκBα. Interestingly, these structures reveal the molecular basis by which βTrCP can recognize and bind both consensus and nonconsensus degron peptides and reveal an overall general plasticity in degron binding mode. We also provide a biochemical assessment of the binding affinities of these peptides for βTrCP, adding further insight into the molecular interactions observed in the crystal structures. Finally, computational analyses of the βTrCP complexes identify opportunities for potential molecular glue approaches.

Indexed as

beta-Transducin Repeat-Containing ProteinsBinding SitesCrystallography, X-RayDegronsHumansModels, MolecularProtein BindingProtein Conformationbeta-Transducin Repeat-Containing Proteins

Identifiers

PMID41891920
PMCPMC13097077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.